Market Summary: In 2022, the global market size for rheumatoid arthritis drugs was USD 24.89 billion, projected to reach USD 38.61 billion by 2032, with a forecasted revenue CAGR of 5%. Rheumatoid arthritis, a chronic autoimmune disease affecting joints and causing swelling, discomfort, is increasingly prevalent globally, impacting approximately 1.3 million people in the U.S. Factors...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian